Walker; Laura Marjorie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Walker; Laura Marjorie.The latest application filed is for "monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with broad and potent neutralizing activity".

Company Profile

7.8.8

Walker; Laura Marjorie - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Grant 11,319,362 - Chan-Hui , et al. May 3, 2	2022-05-03
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20210040186 - Chan-Hui; Po-Ying ; et al.	2021-02-11
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,865,234 - Chan-Hui , et al. December 15, 2	2020-12-15
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190338017 - Chan-Hui; Po-Ying ; et al.	2019-11-07
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,407,493 - Chan-Hui , et al. Sept	2019-09-10
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190169273 - Chan-Hui; Po-Ying ; et al.	2019-06-06
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,239,934 - Chan-Hui , et al.	2019-03-26
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20190031742 - Chan-Hui; Po-Ying ; et al.	2019-01-31
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,920,111 - Chan-Hui , et al. March 20, 2	2018-03-20
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 9,464,131 - Chan-Hui , et al. October 11, 2	2016-10-11
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20150218257 - Chan-Hui; Po-Ying ; et al.	2015-08-06
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,051,362 - Chan-Hui , et al. June 9, 2	2015-06-09
Human Immunodeficiency Virus (hiv)-neutralizing Antibodies App 20140205612 - Chan-Hui; Po-Ying ; et al.	2014-07-24
Human Immunodeficiency Virus (hiv)-neutralizing Antibodies App 20110044994 - Chan-Hui; Po-Ying ; et al.	2011-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.